Financial Analysis
Filing-based analysis. Market pricing is not included. Fundamentals from SEC filings; economic data from FRED and the BLS. About our data
Filing evidence summary
Mixed evidenceCoverage 5/5 core metricsFlagged areas: Solvency & liquidity.
Backward-looking filed evidence under visible rules - not a rating, forecast or investment advice. Missing data is never scored.
Evidence signals
- 1 filing risk check flagged
Flagged areas: Solvency & liquidity.
Why this surfaced
The full financial analysis shows each value, threshold, and sector limitation.
- Revenue was broadly stable
Latest reported annual revenue changed -0.9% from the prior reported annual observation.
Why this surfaced
Direction threshold: above +2% constructive; below -2% caution; otherwise monitor. This is not labeled one-year growth when filing periods have a gap. Period end 2025-12-31.
- Operating margin improved
Operating margin changed +12.2 percentage points from the prior annual period.
Why this surfaced
Direction threshold: more than +1 percentage point constructive; below -1 point caution. Period end 2025-12-31.
- Free cash flow was positive
Latest reported free cash flow was $72M.
Why this surfaced
Free cash flow = operating cash flow minus capital expenditures; positive is supporting evidence, not a valuation conclusion. Period end 2025-12-31.
Core trend metrics
Hover a tile for its exact definition; the Statements tab carries per-cell filing citations.
Where to look next
Risk checks
- Solvency & liquidity
Financial movement
- Cash→ flat
- Long-term debt→ flat
- Inventory→ flat
- Receivables→ flat
- Current assets→ flat
Source & freshness
- Source
- SEC EDGAR XBRL
- Fetched
- 2026-09-06
- Latest period end
- 2025-12-31
- Filings
- EDGAR ↗
Reported segment mix
figures as filed · share of the filed sum · change vs the prior period in the same filing- United States$502M88.4%-0.9% yoy
- Outside the United States$66M11.6%-0.7% yoy
Members sum to the consolidated $568M for this period.
- United States$116M88.2%+5.4% yoy
- Outside the United States$15.6M11.8%+17.1% yoy
Change is against the same quarter a year earlier, as reported in the same 10-Q.
Source: SEC DERA Financial Statement and Notes data sets. Dimensional XBRL facts on the business-segment, product/service and geographic axes; the engine keeps the accession of every figure. Descriptive and educational, not advice.
Peer percentiles
latest fiscal year ending 2025-12-31 · among 4,104 US-listed filers · 318 in Healthcare| Metric | Value | vs all filers | vs sector |
|---|---|---|---|
Revenue latest fiscal-year revenue as filed | $568M | 46thof 3,301 middle third | 58thof 291 middle third |
Revenue growth latest fiscal-year revenue vs the prior fiscal year | -0.9% | 27thof 3,135 bottom third | 22ndof 277 bottom third |
Gross margin gross profit ÷ revenue | 68.3% | 83rdof 1,603 top third | 76thof 212 top third |
Operating margin operating income ÷ revenue | 9.5% | 67thof 2,819 top third | 73rdof 280 top third |
Net margin net income ÷ revenue | 4.0% | 56thof 3,263 middle third | 67thof 290 top third |
Free-cash-flow margin (operating cash flow − |capex|) ÷ revenue | 12.7% | 72ndof 2,679 top third | 79thof 261 top third |
Return on equity net income ÷ stockholders' equity (positive equity only) | 12.3% | 74thof 3,577 top third | 81stof 291 top third |
Stock comp ÷ revenue stock-based compensation ÷ revenue · lower is ranked higher | 2.2% | 50thof 2,895 middle third | 61stof 272 middle third |
Days sales outstanding receivables ÷ revenue × 365 · lower is ranked higher | 82 days | 18thof 2,398 bottom third | 17thof 266 bottom third |
Net debt ÷ operating cash flow net debt ÷ operating cash flow (OCF > 0) · lower is ranked higher | 3.0× | 41stof 1,547 middle third | 36thof 116 middle third |
Cash conversion operating cash flow ÷ net income (net income > 0) | 3.3× | 83rdof 2,135 top third | 83rdof 119 top third |
Cash-flow accrual ratio (net income − operating cash flow) ÷ average total assets · lower is ranked higher | -7.4% | 66thof 3,291 middle third | 54thof 243 middle third |
Balance-sheet accrual ratio change in net operating assets ÷ average net operating assets · lower is ranked higher | 0.8% | 59thof 2,805 middle third | 57thof 213 middle third |
Each filer's latest fiscal year as stored by the nightly crawl; fiscal year ends differ across the universe. A metric ranks only filers for which it is computable from filed facts. Ties split; a rank reads "better than N% of filers" in the metric's own direction. Descriptive and educational, not a rating.
Earnings quality
latest fiscal year ending 2025-12-31 · accruals and cash conversion as filedPer fiscal year from filed facts: cash conversion = operating cash flow / net income (net income > 0); cash-flow accrual ratio = (net income - operating cash flow) / average total assets; balance-sheet accrual ratio = change in net operating assets / average net operating assets, NOA = (assets - cash) - (liabilities - debt). Descriptive; a missing input yields a missing ratio. High accrual ratios and cash conversion well below one are the measures the accruals literature associates with less persistent earnings; they are screens to read the cash-flow statement with, not conclusions. The per-year series is part of Pro risk analysis.
Point-in-time ledger
first-reported vs latest filing · periods since 2020-01-01 · 22 changed periods| Line item | Period | First reported | Latest filing | Change | Filings |
|---|---|---|---|---|---|
| Capital expenditure PaymentsToAcquirePropertyPlantAndEquipment | fiscal year 2020-12-31 | $4.09M 10-K 2022-03-11 | $16.6M 10-K 2023-03-31 | +305.1% | first · latest |
| Capital expenditure PaymentsToAcquirePropertyPlantAndEquipment | fiscal year 2022-12-31 | $10M 10-K 2023-03-31 | $1.48M 10-K 2025-03-11 | -85.3% | first · latest · 3 filings carry it |
| Capital expenditure PaymentsToAcquirePropertyPlantAndEquipment | fiscal year 2021-12-31 | $7.37M 10-K 2022-03-11 | $13.5M 10-K 2024-03-12 | +83.5% | first · latest · 3 filings carry it |
| Goodwill Goodwill | balance at 2022-12-31 | $13.8M 10-K 2023-03-31 | $7.46M 10-K 2024-03-12 | -45.8% | first · latest · 5 filings carry it |
| Intangibles IntangibleAssetsNetExcludingGoodwill | balance at 2022-12-31 | $1.04B 10-K 2023-03-31 | $640M 10-K 2024-03-12 | -38.4% | first · latest · 5 filings carry it |
| Operating income OperatingIncomeLoss | quarter 2022-10-01 | -$201M 10-Q 2022-11-21 | -$127M 10-Q 2023-11-07 | +36.9% | first · latest |
| Operating income OperatingIncomeLoss | fiscal year 2022-12-31 | -$251M 10-K 2023-03-31 | -$167M 10-K 2025-03-11 | +33.4% | first · latest · 3 filings carry it |
| Stock-based compensation ShareBasedCompensation | fiscal year 2024-12-31 | $10.1M 10-K 2025-03-11 | $13.3M 10-K 2026-03-05 | +32.0% | first · latest |
| Operating income OperatingIncomeLoss | fiscal year 2024-12-31 | -$12M 10-K 2025-03-11 | -$15.2M 10-K 2026-03-05 | -26.9% | first · latest |
| Depreciation and amortization DepreciationDepletionAndAmortization | fiscal year 2022-12-31 | $66.8M 10-K 2023-03-31 | $55.4M 10-K 2025-03-11 | -17.1% | first · latest · 3 filings carry it |
| Stock-based compensation ShareBasedCompensation | quarter 2024-03-30 | $2.59M 10-Q 2024-05-07 | $2.99M 10-Q 2025-05-06 | +15.4% | first · latest |
| Total liabilities Liabilities | balance at 2021-12-31 | $692M 10-K 2022-03-11 | $618M 10-K 2024-03-12 | -10.7% | first · latest · 9 filings carry it |
| Operating income OperatingIncomeLoss | quarter 2024-09-28 | $4.07M 10-Q 2024-11-05 | $3.65M 10-Q 2025-11-04 | -10.5% | first · latest |
| Net income NetIncomeLoss | fiscal year 2024-12-31 | -$33.5M 10-K 2025-03-11 | -$36.1M 10-K 2026-03-05 | -7.7% | first · latest |
| Operating income OperatingIncomeLoss | quarter 2024-03-30 | $5.33M 10-Q 2024-05-07 | $4.93M 10-Q 2025-05-06 | -7.5% | first · latest |
| Operating income OperatingIncomeLoss | quarter 2024-06-29 | -$29.4M 10-Q 2024-08-06 | -$31.5M 10-Q 2025-08-06 | -7.2% | first · latest |
| Net income NetIncomeLoss | quarter 2024-09-28 | -$4.82M 10-Q 2024-11-05 | -$5.17M 10-Q 2025-11-04 | -7.1% | first · latest |
| Net income NetIncomeLoss | quarter 2024-06-29 | -$24M 10-Q 2024-08-06 | -$25.7M 10-Q 2025-08-06 | -7.0% | first · latest |
| Net income NetIncomeLoss | quarter 2024-03-30 | -$4.57M 10-Q 2024-05-07 | -$4.89M 10-Q 2025-05-06 | -7.0% | first · latest |
| Total liabilities Liabilities | balance at 2022-12-31 | $1.03B 10-K 2023-03-31 | $960M 10-K 2024-03-12 | -7.0% | first · latest · 5 filings carry it |
| Cash CashAndCashEquivalentsAtCarryingValue | balance at 2022-12-31 | $31.8M 10-K 2023-03-31 | $30.2M 10-K 2024-03-12 | -5.1% | first · latest · 5 filings carry it |
| Stockholders' equity StockholdersEquity | balance at 2022-12-31 | $317M 10-K 2023-03-31 | $325M 10-K 2024-03-12 | +2.7% | first · latest · 5 filings carry it |
First filing reporting each period vs the latest filing carrying it (10-K and 10-Q only, periods since 2020, the extractor's winning tag per concept); a change under 0.5% is treated as rounding. A change can be a restatement, a reclassification or a re-tagging in a later comparative column; the two filings are linked so the reader can see which. Descriptive, not a verdict.
Notes by disclosure type
Not available for BVS yet: no footnote text blocks on file for this filer in the ingested DERA files.
Fundamentals from SEC EDGAR. Scores, the DCF, and every model shown are educational analysis, not investment advice or price predictions.